These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8004701)

  • 1. Studies on anti-platelet agents. II. Synthesis and platelet-inhibitory activity of 5-methyl-4-(3-pyridyl)-2-(substituted benzimidazol-5-yl)imidazoles.
    Tanaka A; Ito K; Nishino S; Motoyama Y; Takasugi H
    Chem Pharm Bull (Tokyo); 1994 Mar; 42(3):560-9. PubMed ID: 8004701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on antiplatelet agents. I. Synthesis and platelet inhibitory activity of 5-alkyl-2-aryl-4-pyridylimidazoles.
    Tanaka A; Ito K; Nishino S; Motoyama Y; Takasugi H
    Chem Pharm Bull (Tokyo); 1992 Dec; 40(12):3206-13. PubMed ID: 1294322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on anti-platelet agents. IV. A series of 2-substituted 4,5-bis(4-methoxyphenyl)pyrimidines as novel anti-platelet agents.
    Tanaka A; Motoyama Y; Takasugi H
    Chem Pharm Bull (Tokyo); 1994 Sep; 42(9):1828-34. PubMed ID: 7954934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,4-Dihydropyridines as antagonists of platelet activating factor. 1. Synthesis and structure-activity relationships of 2-(4-heterocyclyl)phenyl derivatives.
    Cooper K; Fray MJ; Parry MJ; Richardson K; Steele J
    J Med Chem; 1992 Aug; 35(17):3115-29. PubMed ID: 1507200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Synthesis and platelet aggregation inhibitory activity of analogues of 4-([2-(1H-imidazol-1-yl)-1-(4-substituted-phenyl)ethoxy]methyl)benzoic acids].
    Wu QY; Yang JQ
    Yao Xue Xue Bao; 1991; 26(10):741-6. PubMed ID: 1823715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and structure-activity relationship studies of novel 1-[(1-acyl-4-piperidyl)methyl]-1H-2- methylimidazo[4,5-c]pyridine derivatives as potent, orally active platelet-activating factor antagonists.
    Carceller E; Merlos M; Giral M; Balsa D; García-Rafanell J; Forn J
    J Med Chem; 1996 Jan; 39(2):487-93. PubMed ID: 8558517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and inhibitory activity on platelet aggregation of 13'-aza and other omega-chain modified BW245C analogues.
    Barraclough P; Brockwell M; Caldwell AG; Demaine DA; Harris CJ; King WR; Stepney RJ; Wharton CJ; Whittle BJ
    Arch Pharm (Weinheim); 1994 May; 327(5):307-17. PubMed ID: 8010883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and platelet aggregation inhibitory activity of diphenylazole derivatives. I. Thiazole and imidazole derivatives.
    Seko N; Yoshino K; Yokota K; Tsukamoto G
    Chem Pharm Bull (Tokyo); 1991 Mar; 39(3):651-7. PubMed ID: 2070443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet agents based on cyclooxygenase inhibition without ulcerogenesis. Evaluation and synthesis of 4,5-bis(4-methoxyphenyl)-2-substituted-thiazoles.
    Tanaka A; Sakai H; Motoyama Y; Ishikawa T; Takasugi H
    J Med Chem; 1994 Apr; 37(8):1189-99. PubMed ID: 8164261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and inhibitory effect on platelet aggregation and antihypertensive activity of 1-hydroxy-2,5-dihydro-1H-imidazole-2-carboxylic acid 3-oxides, 1,3-dihydroxyimidazolidine-2-carboxylic acids, and 1,4-dihydroxy-2,3-piperazinediones.
    Tikhonov YaA ; Mazhukin DG; Grigor'eva LN; Khlestkin VK; Voinova NN; Syropyatov YaB ; Shirinkina SS; Volodarsky LB
    Arch Pharm (Weinheim); 1999 Sep; 332(9):305-8. PubMed ID: 10520299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thromboxane synthetase inhibitors. I. Synthesis of some imidazolylarylmethanols and their inhibitory activity on platelet aggregation].
    Tsuruda M; Mikashima H; Oe T; Kawasaki K; Setoguchi S; Naka Y; Tahara T
    Yakugaku Zasshi; 1989 Jan; 109(1):33-45. PubMed ID: 2732902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on anti-platelet agents. V. Synthesis and structure-activity relationship of 3-substituted 5,6-bis(4-methoxyphenyl)-1,2,4-triazines.
    Tanaka A; Sakai H; Ishikawa T; Motoyama Y; Takasugi H
    Chem Pharm Bull (Tokyo); 1994 Sep; 42(9):1835-40. PubMed ID: 7954935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational Design and Synthesis of 1-(Arylideneamino)-4-aryl-1H-imidazole-2-amine Derivatives as Antiplatelet Agents.
    Amidi S; Esfahanizadeh M; Tabib K; Soleimani Z; Kobarfard F
    ChemMedChem; 2017 Jun; 12(12):962-971. PubMed ID: 28494138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and in vitro anti-platelet aggregation activities of 2-methoxy-5-arylamido-N-(pyridin-3-yl-methyl)benzamides.
    Wang Y; Wang X; Chen X; Liu X
    Arch Pharm (Weinheim); 2019 Jan; 352(1):e1800257. PubMed ID: 30500077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of blood platelet cAMP phosphodiesterase. 2. Structure-activity relationships associated with 1,3-dihydro-2H-imidazo[4,5-b]quinolin-2-ones substituted with functionalized side chains.
    Meanwell NA; Pearce BC; Roth HR; Smith EC; Wedding DL; Wright JJ; Buchanan JO; Baryla UM; Gamberdella M; Gillespie E
    J Med Chem; 1992 Jul; 35(14):2672-87. PubMed ID: 1321910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiotonic agents. 9. Synthesis and biological evaluation of a series of (E)-4,5-dihydro-6-[2-[4-(1H-imidazol-1-yl)phenyl]ethenyl]-3 (2H)-pyridazinones: a novel class of compounds with positive inotropic, antithrombotic, and vasodilatory activities for the treatment of congestive heart failure.
    Sircar I; Steffen RP; Bobowski G; Burke SE; Newton RS; Weishaar RE; Bristol JA; Evans DB
    J Med Chem; 1989 Feb; 32(2):342-50. PubMed ID: 2536438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel antagonists of platelet-activating factor. 2. Synthesis and structure-activity relationships of potent and long-acting heterofused [1,5]benzodiazepine and [1,4]diazepine derivatives of 2-methyl-1-phenylimidazo[4,5-c]pyridine.
    Fray MJ; Bull DJ; Cooper K; Parry MJ; Stefaniak MH
    J Med Chem; 1995 Sep; 38(18):3524-35. PubMed ID: 7658439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of Hexahydrocyclopentimidazol-2-(1H)-one derivatives displaying selective DP-receptor agonist properties.
    Barraclough P; Bolofo ML; Giles H; Gillam J; Harris CJ; Kelly MG; Leff P; McNeill A; Robertson AD; Stepney RJ; Whittle BJ
    Bioorg Med Chem; 1996 Jan; 4(1):81-90. PubMed ID: 8689243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel antiasthmatic agents with dual activities of thromboxane A2 synthetase inhibition and bronchodilation. IV. 2-[2-(1-Imidazolyl)ethyl]-4-(3-pyridyl)-1(2H)-phthalazinones.
    Yamaguchi M; Koga T; Kamei K; Akima M; Maruyama N; Kuroki T; Hamana M; Ohi N
    Chem Pharm Bull (Tokyo); 1994 Sep; 42(9):1850-3. PubMed ID: 7954937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and inhibitory effects of 1,4,5-trialkyl-2-thioimidazole derivatives on platelet aggregation.
    Fatimi J; Lagorce JF; Chabernaud ML; Buxeraud J; Raby C
    Boll Chim Farm; 1994 Mar; 133(3):151-5. PubMed ID: 8011274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.